Research Summary

Citrulline improves microvascular function and muscle strength in T2D

Key finding

CITS increased the LnRHI (Δ0.11 ± 0.16 vs. Δ−0.08 ± 0.24, p < 0.05)

Citrulline supplementation improved microvascular function and muscle strength in patients with type 2 diabetes compared to placebo.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Some Concerns bias
Last updated July 8, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Citrulline supplementation, Placebo

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Primary outcome

Log-transformed reactive hyperemia index (LnRHI)

Comparator

Placebo

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

Citrulline supplementation improved microvascular function and muscle strength in patients with type 2 diabetes compared to placebo.

Clinical relevance

Improving microvascular function and muscle strength in patients with type 2 diabetes can enhance overall health and reduce complications associated with the disease. Citrulline supplementation may offer a simple, effective strategy to support these improvements, potentially leading to better management of diabetes-related issues.

Keep in mind

Limited sample size may affect generalizability. Short duration of the study may not capture long-term effects. Potential confounding factors not fully controlled.

Published in

Journal Reference

Publication details and source links for this paper.

Arturo F, Katherine ND, Danielle EL, Yejin K, Carlo MP. Citrulline Supplementation Improves Microvascular Function and Muscle Strength in Patients with Type 2 Diabetes. Nutrients. 2025;17(17):2790. doi:10.3390/nu17172790

Save this study and add notes to your research library.

Main Effects

Citrulline supplementation increased the LnRHI by Δ0.11 ± 0.16 (p < 0.05).

Citrulline supplementation increased the TOI range by Δ2.6 ± 3.3% (p < 0.01).

Citrulline supplementation increased calf muscle strength by Δ1.5 ± 2.8 kg (p < 0.05).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to L-citrulline supplementation (Phase 1) and Glucose iAUC (OGTT), Log-transformed reactive hyperemia index (LnRHI), Muscular strength, and 3 more.

Primary intervention

L-citrulline supplementation (Phase 1)

Primary outcomes

  • Glucose iAUC (OGTT)
  • Log-transformed reactive hyperemia index (LnRHI)
  • Muscular strength

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

6

Evidence pairs

109

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

HarmfulIncrease

Glucose iAUC (OGTT)

L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)

L-citrulline supplementation (Phase 1) → Glucose iAUC (OGTT)

Evidence profile

HarmfulIncreaseGlycemic Control
Unlock full evidence details
StrongIncrease

Log-transformed reactive hyperemia index (LnRHI)

L-citrulline supplementation (Phase 1) → Log-transformed reactive hyperemia index (LnRHI)

L-citrulline supplementation (Phase 1) → Log-transformed reactive hyperemia index (LnRHI)

Evidence profile

StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease

Muscular strength

L-citrulline supplementation (Phase 1) → Muscular strength

L-citrulline supplementation (Phase 1) → Muscular strength

Evidence profile

StrongIncreaseMetabolic Health
Unlock full evidence details
StrongIncrease

Plasma arginine levels

L-citrulline supplementation (Phase 1) → Plasma arginine levels

L-citrulline supplementation (Phase 1) → Plasma arginine levels

Evidence profile

StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease

Tissue Oxygen Index (TOI) Range

L-citrulline supplementation (Phase 1) → Tissue Oxygen Index (TOI) Range

L-citrulline supplementation (Phase 1) → Tissue Oxygen Index (TOI) Range

Evidence profile

StrongIncreaseMetabolic Health
Unlock full evidence details
StrongIncrease

TOI hyperemic response

L-citrulline supplementation (Phase 1) → TOI hyperemic response

L-citrulline supplementation (Phase 1) → TOI hyperemic response

Evidence profile

StrongIncreaseClinical Outcomes
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Citrulline raised plasma arginine levels by Δ43 μM/L (p < 0.001).
  • Citrulline improved TOI hyperemic response by Δ1.2% (p < 0.05).
  • Placebo did not significantly change any measured outcomes.
who this applies

Who this applies to

  • Adults diagnosed with type 2 diabetes.
  • Patients experiencing muscle weakness or vascular issues.
keep in mind

Keep in Mind

  • Results may not apply to other types of diabetes.
  • Further research needed to confirm long-term benefits.
  • Study findings are based on a specific population sample.
between the lines

Between the Lines

  • Limited sample size may affect generalizability.
  • Short duration of the study may not capture long-term effects.
  • Potential confounding factors not fully controlled.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

This study contributes to evidence on L-citrulline supplementation (Phase 1) and Log-transformed reactive hyperemia index (LnRHI), L-citrulline supplementation (Phase 1) and Muscular Strength.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Does L-citrulline supplementation (Phase 1) improve muscular strength?

Emerging Evidence

L-citrulline supplementation (Phase 1) appears to improve Muscular strength.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Muscular strength

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does L-citrulline supplementation (Phase 1) improve log-transformed reactive hyperemia index (lnrhi)?

Emerging Evidence

L-citrulline supplementation (Phase 1) appears to improve Log-transformed reactive hyperemia index (LnRHI).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Log-transformed reactive hyperemia index (LnRHI)

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does L-citrulline supplementation (Phase 1) improve plasma arginine levels?

Emerging Evidence

L-citrulline supplementation (Phase 1) appears to improve Plasma arginine levels.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Plasma arginine levels

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does L-citrulline supplementation (Phase 1) improve toi hyperemic response?

Emerging Evidence

L-citrulline supplementation (Phase 1) appears to improve TOI hyperemic response.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    TOI hyperemic response

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.